- Home
- NRO vs STXS Comparison
NRO vs STXS Comparison
Compare NRO & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- STXS
- Stock Information
- Founded
- NRO 2003
- STXS 1990
- Country
- NRO United States
- STXS United States
- Employees
- NRO N/A
- STXS N/A
- Industry
- NRO Finance/Investors Services
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NRO Finance
- STXS Health Care
- Exchange
- NRO Nasdaq
- STXS Nasdaq
- Market Cap
- NRO 187.8M
- STXS 189.8M
- IPO Year
- NRO N/A
- STXS 2004
- Fundamental
- Price
- NRO $3.51
- STXS $2.12
- Analyst Decision
- NRO
- STXS Strong Buy
- Analyst Count
- NRO 0
- STXS 2
- Target Price
- NRO N/A
- STXS $4.50
- AVG Volume (30 Days)
- NRO 239.4K
- STXS 422.5K
- Earning Date
- NRO 01-01-0001
- STXS 03-03-2025
- Dividend Yield
- NRO 11.41%
- STXS N/A
- EPS Growth
- NRO N/A
- STXS N/A
- EPS
- NRO N/A
- STXS N/A
- Revenue
- NRO N/A
- STXS $25,143,000.00
- Revenue This Year
- NRO N/A
- STXS $1.16
- Revenue Next Year
- NRO N/A
- STXS $55.65
- P/E Ratio
- NRO N/A
- STXS N/A
- Revenue Growth
- NRO N/A
- STXS N/A
- 52 Week Low
- NRO $2.51
- STXS $1.66
- 52 Week High
- NRO $3.45
- STXS $3.29
- Technical
- Relative Strength Index (RSI)
- NRO 43.23
- STXS 43.74
- Support Level
- NRO $3.52
- STXS $2.21
- Resistance Level
- NRO $3.62
- STXS $2.72
- Average True Range (ATR)
- NRO 0.08
- STXS 0.16
- MACD
- NRO 0.02
- STXS -0.02
- Stochastic Oscillator
- NRO 54.84
- STXS 10.37
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. The fund invests in sectors, such as apartments, Data Centers, Infrastructure REITs, Manufactured Homes, Office, Regional Malls and others.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.